A New Path to Earlier Alzheimer’s Detection | Dr. Jonathan Hill

A New Path to Earlier Alzheimer’s Detection | Dr. Jonathan Hill

What if scientists could read DNA differently, uncover biological signals earlier, and eventually diagnose disease before symptoms become obvious?

Dr. Jonathon Hill joins BioTalk Unzipped to explore nanopore sequencing, genetics, epigenetics, artificial intelligence, addiction research, fertility, and the search for earlier biomarkers of Alzheimer’s disease.

Jonathon explains how nanopore sequencing works and why the ability to analyze native DNA and RNA can provide researchers with information extending beyond the underlying genetic sequence.

His scientific interests also connect with a deeply personal passion for biodiversity. Jonathon describes his time in Brazil and his dream of establishing a nanopore sequencing laboratory in the Amazon to study its extraordinary biological diversity.

The conversation then turns toward AI and genetics, including research into the genetic underpinnings of tobacco addiction. Jonathon discusses both the potential of AI to accelerate biological discovery and the risks of treating opaque models as scientific explanations.

Later, he explains work involving cell-free DNA and fertility before discussing one of the most consequential areas of his research: DNA methylation signatures that may eventually contribute to earlier detection of Alzheimer’s disease.

It is a fascinating look at what becomes possible when genomics, computation, and molecular biology begin converging.

Chapters

00:00 - Introduction

02:51 - Donation to Rainforest Trust and Jonathon’s time in Brazil

06:37 - How nanopore sequencing works

12:45 - New News: AI and the genetic code of tobacco addiction

15:20 - Using AI in nanopore sequencing at Wasatch Labs and Diagnostics

21:14 - Finding cell-free DNA for fertility treatments

22:56 - Breakthrough: Finding early biomarkers for Alzheimer’s disease

Selected quotes“Biology is not rocket science, it’s much harder.”“Better diagnosis comes better treatment.”Connect with Dr. Jonathon Hill

Dr. Jonathon Hill

https://www.linkedin.com/in/jonathon-t-hill/

Wasatch Labs

https://www.wasatchbiolabs.com/

Connect with the hosts

Dr. Chad Briscoe

https://www.linkedin.com/in/chadbriscoe/

Gregory Austin

https://www.linkedin.com/in/gregoryaustin1/

New News

Breaking the Genetic Code of Tobacco Addiction:

https://neurosciencenews.com/genetics-tobacco-addiction-ai-25937/

Additional resources and image credits

Rainforest Trust: https://www.rainforesttrust.org/

EnviroBuild / Rainforest Trust: https://www.envirobuild.com/blog/rainforest-trust

Fire Sponge: https://stock.adobe.com/

Oxford Nanopore Technologies, How Nanopore Sequencing Works: https://www.youtube.com/watch?v=RcP85JHLmnI

Keywords

nanopore sequencing, genomics, epigenetics, DNA methylation, Alzheimer’s disease, AI, genetic research, tobacco addiction, biomarkers

#nanopore #genetics #epigenetics #AI #Alzheimers #DNA #biotechnology

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(45)

Why Gene Therapy Is Still So Hard to Manufacture at Scale | Phillip Ramsey

Why Gene Therapy Is Still So Hard to Manufacture at Scale | Phillip Ramsey

Why is gene therapy still so difficult to manufacture at scale after decades of progress?Phillip Ramsey, Chief Technical Officer at Sangamo Therapeutics, joins BioTalk Unzipped for a candid conversati...

8 Aug 11min

Her Daughter’s Brain Tumor Turned Her Into a Biotech Founder | Tracy Ryan

Her Daughter’s Brain Tumor Turned Her Into a Biotech Founder | Tracy Ryan

A mother’s search for answers to her daughter’s relentless brain tumor led her into natural killer cell biology, cancer immunotherapy, and biotech entrepreneurship.Sponsored by Leucentra, https://leuc...

20 Jul 1h 4min

The Future of Oncology Drug Development | Dr. Lakshmi Amaravadi

The Future of Oncology Drug Development | Dr. Lakshmi Amaravadi

Oncology drug development is becoming more complex, and bioanalysis can no longer be treated as simple drug measurement.Sponsored by Leucentra, https://leucentra.com/Inspired by science, empowered by ...

11 Jun 29min

Active Machine Learning for Drug Discovery & Nanomedicine with Dr. Daniel Reker

Active Machine Learning for Drug Discovery & Nanomedicine with Dr. Daniel Reker

Can artificial intelligence help make cancer therapies safer, more targeted, and more effective?In this episode of BioTalk Unzipped, Gregory Austin sits down with Dr. Daniel Reker, Assistant Professor...

25 Apr 50min

Why Haven’t We Cured Cancer Yet? | Dr. Bob Liu Explains

Why Haven’t We Cured Cancer Yet? | Dr. Bob Liu Explains

Why haven’t we cured cancer yet? A Genentech scientist explains the real reason.In this episode of BioTalk Unzipped, Gregory Austin and Dr. Chad Briscoe sit down with Dr. Bob Liu, Senior Principal Sci...

19 Mar 1h

The Intersection of Biotech, Patent Law, and AI with Dr. Kate Neville, IP Attorney

The Intersection of Biotech, Patent Law, and AI with Dr. Kate Neville, IP Attorney

Recorded October 31, 2025In this episode of BioTalk Unzipped, Gregory Austin and Dr. Chad Briscoe sit down with Dr. Kate Neville, immunologist turned seasoned biotech patent attorney at Marshall, Gers...

16 Feb 52min

Long-acting Cell-Based Gene Therapy, Fabry Disease and Beyond with Glafabra CEO, Dr. Chris Hopkins

Long-acting Cell-Based Gene Therapy, Fabry Disease and Beyond with Glafabra CEO, Dr. Chris Hopkins

In this episode of BioTalk Unzipped, hosts Gregory Austin and Dr. Chad Briscoe sit down with Glafabra CEO: Dr. Chris Hopkins, geneticist, biochemist, and biotech entrepreneur, to explore the science a...

22 Des 202549min

Fail Fast, Learn Faster: Drug Development in Rare Disease with Dr. Binodh DeSilva

Fail Fast, Learn Faster: Drug Development in Rare Disease with Dr. Binodh DeSilva

In this episode of BioTalk Unzipped, Gregory Austin and Dr. Chad Briscoe sit down with Dr. Binodh DeSilva, Senior Vice President of Bioanalysis at Ultragenyx Pharmaceutical, to explore the science and...

23 Okt 202531min

Populært innen Business og økonomi

stopp-verden
lydartikler-fra-aftenposten
dine-penger-pengeradet
rss-penger-polser-og-politikk
e24-podden
rss-borsmorgen-okonominyhetene
rss-skravla-gar
lederpodden
rss-pa-konto
utbytte
pengepodden-2
livet-pa-veien-med-jan-erik-larssen
morgenkaffen-med-finansavisen
finansredaksjonen
tid-er-penger-en-podcast-med-peter-warren
liberal-halvtime
rss-markedspuls-2
pengesnakk
rss-politisk-preik
okonomiamatorene